{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:02:54Z","timestamp":1782342174041,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,1,22]],"date-time":"2002-01-22T00:00:00Z","timestamp":1011657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1038\/ni758","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:30:32Z","timestamp":1027657832000},"page":"196-200","source":"Crossref","is-referenced-by-count":2008,"title":["Small anti-viral compounds activate immune cells via the TLR7 MyD88\u2013dependent signaling pathway"],"prefix":"10.1038","volume":"3","author":[{"given":"Hiroaki","family":"Hemmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneyasu","family":"Kaisho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Sanjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Akira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,1,22]]},"reference":[{"key":"BFni758_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)80412-2","volume":"91","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov, R. & Janeway, C. A. Jr Innate immunity: the virtues of a nonclonal system of recognition. Cell 91, 295\u2013298 (1997).","journal-title":"Cell"},{"key":"BFni758_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/35021228","volume":"406","author":"A Aderem","year":"2000","unstructured":"Aderem, A. & Ulevitch, R. J. Toll-like receptors in the induction of the innate immune response. Nature 406, 782\u2013787 (2000).","journal-title":"Nature"},{"key":"BFni758_CR3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol. 2, 675\u2013680 (2001).","journal-title":"Nature Immunol."},{"key":"BFni758_CR4","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"BFni758_CR5","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","author":"K Hoshino","year":"1999","unstructured":"Hoshino, K. et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749\u20133752 (1999).","journal-title":"J. Immunol."},{"key":"BFni758_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099\u20131103 (2001).","journal-title":"Nature"},{"key":"BFni758_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740\u2013745 (2000).","journal-title":"Nature"},{"key":"BFni758_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.163.1.1","volume":"163","author":"A Yoshimura","year":"1999","unstructured":"Yoshimura, A. et al. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163, 1\u20135 (1999).","journal-title":"J. Immunol."},{"key":"BFni758_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1126\/science.285.5428.732","volume":"285","author":"HD Brightbill","year":"1999","unstructured":"Brightbill, H. D. et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285, 732\u2013736 (1999).","journal-title":"Science"},{"key":"BFni758_CR10","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1126\/science.285.5428.736","volume":"285","author":"AO Aliprantis","year":"1999","unstructured":"Aliprantis, A. O. et al. Cell activation and apoptosis by bacterial lipoproteins through Toll- like receptor-2. Science 285, 736\u2013739 (1999).","journal-title":"Science"},{"key":"BFni758_CR11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/44605","volume":"401","author":"DM Underhill","year":"1999","unstructured":"Underhill, D. M. et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811\u2013815 (1999).","journal-title":"Nature"},{"key":"BFni758_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","volume":"11","author":"O Takeuchi","year":"1999","unstructured":"Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443\u2013451 (1999).","journal-title":"Immunity"},{"key":"BFni758_CR13","doi-asserted-by":"publisher","first-page":"13766","DOI":"10.1073\/pnas.250476497","volume":"97","author":"A Ozinsky","year":"2000","unstructured":"Ozinsky, A. et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl Acad. Sci. USA 97, 13766\u201313771 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni758_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","volume":"13","author":"O Takeuchi","year":"2001","unstructured":"Takeuchi, O. et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13, 933\u2013940 (2001).","journal-title":"Int. Immunol."},{"key":"BFni758_CR15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-\u03baB by Toll-like receptor 3. Nature 413, 732\u2013738 (2001).","journal-title":"Nature"},{"key":"BFni758_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1369-5274(99)00045-4","volume":"3","author":"J-L Imler","year":"2000","unstructured":"Imler, J.-L. & Hoffmann, J. A. Signaling mechanisms in the antimicrobial host defense of Drosophila. Curr. Opin. Microbiol. 3, 16\u201322 (2000).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFni758_CR17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4049\/jimmunol.164.2.554","volume":"164","author":"O Takeuchi","year":"2000","unstructured":"Takeuchi, O. et al. Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164, 554\u2013557 (2000).","journal-title":"J. Immunol."},{"key":"BFni758_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1084\/jem.192.4.595","volume":"192","author":"H H\u00e4cker","year":"2000","unstructured":"H\u00e4cker, H. et al. Immune cell activation by bacterial CpG-DNA through myeloid differential marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192, 595\u2013600 (2000).","journal-title":"J. Exp. Med."},{"key":"BFni758_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0960-9822(00)00700-4","volume":"10","author":"M Schnare","year":"2000","unstructured":"Schnare, M., Holt, A. C., Takeda, K., Akira, S. & Medzhitov R. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr. Biol. 10, 1139\u20131142 (2000).","journal-title":"Curr. Biol."},{"key":"BFni758_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1074-7613(00)80086-2","volume":"11","author":"T Kawai","year":"1999","unstructured":"Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115\u2013122 (1999).","journal-title":"Immunity"},{"key":"BFni758_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","volume":"21","author":"RL Miller","year":"1999","unstructured":"Miller, R. L., Gerster, J. F., Owens, M. L., Slade, H. B. & Tomai, M. A. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int. J. Immunopharmacol. 21, 1\u201314 (1999).","journal-title":"Int. J. Immunopharmacol."},{"key":"BFni758_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/jlb.58.3.365","volume":"58","author":"TL Testerman","year":"1995","unstructured":"Testerman, T. L. et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J. Leukoc. Biol. 58, 365\u2013372 (1995).","journal-title":"J. Leukoc. Biol."},{"key":"BFni758_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/jir.1994.14.81","volume":"14","author":"CE Weeks","year":"1994","unstructured":"Weeks, C. E. & Gibson, S. J. Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro. J. Interferon Res. 14, 81\u201385 (1994).","journal-title":"J. Interferon Res."},{"key":"BFni758_CR24","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1128\/AAC.38.9.2059","volume":"38","author":"CJ Harrison","year":"1994","unstructured":"Harrison, C. J., Miller, R. L. & Bernstein, D. I. Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs. Antimicrob. Agents Chemother. 38, 2059\u20132064 (1994).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFni758_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1128\/AAC.32.5.678","volume":"32","author":"M Chen","year":"1988","unstructured":"Chen, M., Griffith, B. P., Lucia, H. L. & Hsiung, G. D. Efficacy of S26308 against guinea pig cytomegalovirus infection. Antimicrob. Agents Chemother. 32, 678\u2013683 (1988).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFni758_CR26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1086\/319262","volume":"183","author":"DI Bernstein","year":"2001","unstructured":"Bernstein, D. I., Harrison, C. J., Tomai, M. A. & Miller, R.L. Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. J. Infect. Dis. 183, 844\u2013849 (2001).","journal-title":"J. Infect. Dis."},{"key":"BFni758_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/sti.76.3.162","volume":"76","author":"G von Krogh","year":"2000","unstructured":"von Krogh, G., Lacey, C. J., Gross, G., Barrasso, R. & Schneider, A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex. Transm. Infect. 76, 162\u2013168 (2000).","journal-title":"Sex. Transm. Infect."},{"key":"BFni758_CR28","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1001\/jama.285.17.2182-JMN0502-2-1","volume":"285","author":"J Stephenson","year":"2001","unstructured":"Stephenson, J. New therapy promising for genital herpes. J. Am. Med. Assoc. 285, 2182\u20132183 (2001).","journal-title":"J. Am. Med. Assoc."},{"key":"BFni758_CR29","first-page":"362","volume":"11","author":"X Du","year":"2000","unstructured":"Du, X., Poltorak, A., Wei, Y. & Beutler B. Three novel mammalian Toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11, 362\u2013371 (2000).","journal-title":"Eur. Cytokine Netw."},{"key":"BFni758_CR30","first-page":"372","volume":"11","author":"T-H Chuang","year":"2000","unstructured":"Chuang, T.-H. & Ulevitch, R. J. Cloning and characterization of a sub-family of human Toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11, 372\u2013378 (2000).","journal-title":"Eur. Cytokine Netw."},{"key":"BFni758_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0065-2776(08)60790-7","volume":"73","author":"H Wagner","year":"1999","unstructured":"Wagner, H. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol. 73, 329\u2013368 (1999).","journal-title":"Adv. Immunol."},{"key":"BFni758_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0966-842X(01)02039-X","volume":"9","author":"AM Krieg","year":"2001","unstructured":"Krieg, A. M. Now I know my CpGs. Trends Microbiol. 9, 249\u2013252 (2001).","journal-title":"Trends Microbiol."},{"key":"BFni758_CR33","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/374546a0","volume":"374","author":"AM Krieg","year":"1995","unstructured":"Krieg, A. M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546\u2013549 (1995).","journal-title":"Nature"},{"key":"BFni758_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1349-7006.1994.tb02947.x","volume":"85","author":"T Yamamoto","year":"1994","unstructured":"Yamamoto, T. et al. Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro. Jpn. J. Cancer Res. 85, 775\u2013779 (1994).","journal-title":"Jpn. J. Cancer Res."},{"key":"BFni758_CR35","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.4049\/jimmunol.166.4.2372","volume":"166","author":"D Verthelyi","year":"2001","unstructured":"Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F. & Klinman, D. M. Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166, 2372\u20132377 (2001).","journal-title":"J. Immunol."},{"key":"BFni758_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1006\/cimm.2000.1673","volume":"203","author":"MA Tomai","year":"2000","unstructured":"Tomai, M. A., Imbertson, L. M., Stanczak, T. L., Tygrett, L. T. & Waldschmidt, T. J. The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes. Cell. Immunol. 203, 55\u201362 (2000).","journal-title":"Cell. Immunol."},{"key":"BFni758_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1006\/cimm.2001.1769","volume":"208","author":"GA Bishop","year":"2001","unstructured":"Bishop, G. A. et al. The immune response modifier resiquimod mimics CD40-induced B cell activation. Cell. Immunol. 208, 9\u201317 (2001).","journal-title":"Cell. Immunol."},{"key":"BFni758_CR38","unstructured":"Megyeri, K. et al. Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. Mol. Cell. Biol. 15, 2207\u20132218 (1995)."},{"key":"BFni758_CR39","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.4049\/jimmunol.165.10.5552","volume":"165","author":"GA Bishop","year":"2000","unstructured":"Bishop, G. A. et al. Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848. J. Immunol. 165, 5552\u20135557 (2000).","journal-title":"J. Immunol."},{"key":"BFni758_CR40","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.1073\/pnas.160027697","volume":"97","author":"A Bowie","year":"2000","unstructured":"Bowie, A. et al. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc. Natl Acad. Sci. USA 97, 10162\u201310167 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni758_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/80833","volume":"1","author":"EA Kurt-Jones","year":"2000","unstructured":"Kurt-Jones, E. A. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nature Immunol. 1, 398\u2013401 (2000).","journal-title":"Nature Immunol."},{"key":"BFni758_CR42","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","volume":"284","author":"FP Siegal","year":"1999","unstructured":"Siegal, F. P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835\u20131837 (1999).","journal-title":"Science"},{"key":"BFni758_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/11360","volume":"5","author":"M Cella","year":"1999","unstructured":"Cella, M. et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nature Med. 5, 919\u2013923 (1999).","journal-title":"Nature Med."},{"key":"BFni758_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/89726","volume":"2","author":"Y-J Liu","year":"2001","unstructured":"Liu, Y.-J., Kanzler, H., Soumelis, V. & Gilliet, M. Dendritic cell lineage, plasticity and cross-regulation. Nature Immunol. 2, 585\u2013589 (2001).","journal-title":"Nature Immunol."},{"key":"BFni758_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.194.6.863","volume":"194","author":"N Kadowaki","year":"2001","unstructured":"Kadowaki, N. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863\u2013869 (2001).","journal-title":"J. Exp. Med."},{"key":"BFni758_CR46","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1002\/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H","volume":"31","author":"A Krug","year":"2001","unstructured":"Krug, A. et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026\u20133037 (2001).","journal-title":"Eur. J. Immunol."},{"key":"BFni758_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1006\/cimm.2000.1689","volume":"204","author":"JP Vasilakos","year":"2000","unstructured":"Vasilakos, J. P. et al. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN. Cell. Immunol. 204, 64\u201374 (2000).","journal-title":"Cell. Immunol."},{"key":"BFni758_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","volume":"9","author":"O Adachi","year":"1998","unstructured":"Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143\u2013150 (1998).","journal-title":"Immunity"},{"key":"BFni758_CR49","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1074\/jbc.274.16.10689","volume":"274","author":"JC Chow","year":"1999","unstructured":"Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J. & Gusovsky, F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689\u201310692 (1999).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni758","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:50:43Z","timestamp":1684435843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,22]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["BFni758"],"URL":"https:\/\/doi.org\/10.1038\/ni758","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1003759.40754","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,22]]}}}